Literature DB >> 713418

[Analysis of the hydroxyproline containing serum proteins in connective tissue diseases (author's transl)].

U Langness, B Bleicken.   

Abstract

The serum proteins were fractionated on Sephadex G 200, their hydroxyproline content determined. Three protein peaks (I-III) containing different hydroxyproline concentrations could be separated. In connective tissue disorders accompanied by increased collagen synthesis or collagen degradation, an elevation of hydroxyproline was found in peak II. An increase of hydroxyproline always was associated with an increase of the serum proteins in the same fractions. Hydroxyproline serum levels above normal obviously are due to a certain capacity of the serum proteins binding free hydroxyproline and collagen metabolites.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 713418     DOI: 10.1007/bf01479839

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  6 in total

1.  A HYDROXYPROLINE-CONTAINING, COLLAGEN-LIKE PROTEIN IN PLASMA AND A PROCEDURE FOR ITS ASSAY.

Authors:  E C LEROY; A KAPLAN; S UDENFRIEND; A SJOERDSMA
Journal:  J Biol Chem       Date:  1964-10       Impact factor: 5.157

2.  Fractionation of human-serum proteins by gel filtration.

Authors:  P FLODIN; J KILLANDER
Journal:  Biochim Biophys Acta       Date:  1962-10-08

3.  A specific method for the analysis of hydroxyproline in tissues and urine.

Authors:  D J PROCKOP; S UDENFRIEND
Journal:  Anal Biochem       Date:  1960-11       Impact factor: 3.365

4.  [Serum hyproprotein level as an index for the activity of chronic polyarthritis].

Authors:  U Langness; W Kriegel
Journal:  Klin Wochenschr       Date:  1969-07-01

5.  [The determination of collagen antibodies and the so-called "collagen-like protein" (CLP) in serum in ankylosing spondylitis].

Authors:  U Langness; W Kriegel; P Jahn
Journal:  Verh Dtsch Ges Rheumatol       Date:  1969

6.  COLLAGEN-LIKE PROTEIN IN HUMAN PLASMA.

Authors:  H KEISER; E C LEROY; S UDENFRIEND; A SJOERDSMA
Journal:  Science       Date:  1963-12-27       Impact factor: 47.728

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.